These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31988814)

  • 1. Surface Mould Brachytherapy for Skin Cancers: The British Columbia Cancer Experience.
    Casey S; Awotwi-Pratt J; Bahl G
    Cureus; 2019 Dec; 11(12):e6412. PubMed ID: 31988814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and toxicity outcomes with 3D based-HDR surface mold brachytherapy in skin cancer.
    Yadavalli P; Pareek V; Barthwal M; Bharat R; Mullassery S; Aashita ; Patil P; Sharma A; Sharma DN; Mallick S
    J Cancer Res Ther; 2024 Apr; 20(3):930-934. PubMed ID: 39023600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds - a single-centre experience.
    Laliscia C; Fuentes T; Coccia N; Mattioni R; Perrone F; Paiar F
    Contemp Oncol (Pozn); 2021; 25(1):12-16. PubMed ID: 33911976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes with high-dose-rate surface mould brachytherapy for intra-oral and skin malignancies involving head and neck region.
    Budrukkar A; Dasgupta A; Pandit P; Laskar SG; Murthy V; Upreti RR; Gupta T; Dholam K; Agarwal JP
    J Contemp Brachytherapy; 2017 Jun; 9(3):242-250. PubMed ID: 28725248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two different sizes of Valencia applicators in non-melanoma skin cancer treatment with iridium-192 high-dose-rate brachytherapy.
    Laliscia C; Coccia N; Fuentes T; Perrone F; Paiar F
    J Contemp Brachytherapy; 2021 Dec; 13(6):615-619. PubMed ID: 35079246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
    le Guyader M; Lam Cham Kee D; Thamphya B; Schiappa R; Gautier M; Chand-Fouche ME; Hannoun-Levi JM
    Clin Transl Radiat Oncol; 2022 Jan; 32():15-23. PubMed ID: 34816022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer.
    Lancellotta V; Kovács G; Tagliaferri L; Perrucci E; Rembielak A; Stingeni L; Tramontana M; Hansel K; Colloca G; Saldi S; Valentini V; Aristei C
    J Geriatr Oncol; 2019 May; 10(3):514-517. PubMed ID: 30314955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution study.
    Kalaghchi B; Esmati E; Ghalehtaki R; Gomar M; Jaberi R; Gholami S; Babaloui S; Nabavi M; Sotoudeh S; Khanjani N; Kazemian A; Amouzegar-Hashemi F; Aghili M; Lashkari M
    J Contemp Brachytherapy; 2018 Apr; 10(2):115-122. PubMed ID: 29789760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
    Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
    Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDR brachytherapy for superficial non-melanoma skin cancers.
    Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dosimetric study of electron beam therapy vs. high-dose-rate mould brachytherapy in adjuvant treatment of non-melanoma skin carcinomas of the head and neck region.
    Sen S; Bandyopadhyay A; Pal JK; Ghosh AK; Deb AR
    J Contemp Brachytherapy; 2019 Dec; 11(6):547-553. PubMed ID: 31969913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Dose Rate 192-Ir-Brachytherapy for Basal Cell Carcinoma of the Skin using a 3D Printed Surface Mold.
    Casey S; Bahl G; Awotwi-Pratt JB
    Cureus; 2019 Jun; 11(6):e4913. PubMed ID: 31417833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.
    Yoon SM; Suh R; Abtin F; Moghanaki D; Genshaft S; Kamrava M; Drakaki A; Liu S; Venkat P; Lee A; Chang AJ
    Radiat Oncol; 2021 Jun; 16(1):99. PubMed ID: 34098977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing surface mould brachytherapy for treatment of nasal basal cell carcinoma using customized applicators.
    Barnes EA; Tsao MN; Taggar AS; Ravi A; Paudel MR
    Brachytherapy; 2023; 22(5):665-672. PubMed ID: 37277286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series.
    Delishaj D; Laliscia C; Manfredi B; Ursino S; Pasqualetti F; Lombardo E; Perrone F; Morganti R; Paiar F; Fabrini MG
    J Contemp Brachytherapy; 2015 Dec; 7(6):437-44. PubMed ID: 26816500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing high-dose rate surface mould brachytherapy for carcinoma of eyelid: a practical approach and weekly review.
    Patro KC; Avinash A; Banidutta A; Kundu CR; Bhattacharya PS; Pilaka VKR; Muvvala M; Kumar AA; Aketi S; Karthikeyan K; Madasu BK; Vincent DT
    Radiat Oncol J; 2024 Jun; 42(2):154-159. PubMed ID: 38946078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial high-dose-rate brachytherapy in eyelid cancer.
    Mareco V; Bujor L; Abrunhosa-Branquinho AN; Ferreira MR; Ribeiro T; Vasconcelos AL; Ferreira CR; Jorge M
    Brachytherapy; 2015; 14(4):554-64. PubMed ID: 25959364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience.
    Cho LP; Manuel M; Catalano P; Lee L; Damato AL; Cormack RA; Buzurovic I; Bhagwat M; O'Farrell D; Devlin PM; Viswanathan AN
    Gynecol Oncol; 2016 Dec; 143(3):545-551. PubMed ID: 27720445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
    Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose brachytherapy with non sealed
    Castellucci P; Savoia F; Farina A; Lima GM; Patrizi A; Baraldi C; Zagni F; Vichi S; Pettinato C; Morganti AG; Strigari L; Fanti S
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1511-1521. PubMed ID: 33140131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.